Search Results - "甲状旁腺功能亢进" :: K.UTB vyhledávací portál

Vyzkoušejte nový nástroj s podporou AI Summon Research Assistant BETA

Search alternatives:

Subject ("甲状旁腺功能亢进") »
- Subject ("甲状腺功能亢进")

Loading…

用于降低甲状旁腺激素水平的治疗剂

Year of Publication 25.10.2022

Get full text

Patent

Loading…

CASR调节剂的药物组合物及其方法和用途

Year of Publication 27.08.2024

Get full text

Patent

Loading…

Pharmaceutical compositions of CASR modulators and methods and uses thereof

by KAMBOJ RAJENDER KUMAR, BAKLE, DHANANJAY, SADASHIV, SHAH, CHIRAG ANILKUMAR
Year of Publication 12.08.2022

Get full text

Patent

Loading…

用于降低甲状旁腺激素水平的治疗剂

Year of Publication 08.06.2018

Get full text

Patent

Loading…

Calcimimetics and methods for their use

by TOMLINSON JAMES E, WALTER SARAH, BELL GREGORY
Year of Publication 09.07.2019

Get full text

Patent

Loading…

Therapeutic Agents For Reducing Parathyroid Hormone Levels

by FELIX KARIM, QUN YIN, DEREK MACLEAN, KANAD DAS, AMOS BARUCH
Year of Publication 09.02.2018

Get full text

Patent

Loading…

USE OF 2-METHYLENE-19-NOR-(20S)-1,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM 2--19--(20S)-125- D3

by LORI A. PLUM, JULIA B. ZELLA, MARGARET CLAGETT-DAME, HECTOR F. DELUCA
Year of Publication 15.01.2016

Get full text

Patent

Search alternatives:

用于降低甲状旁腺激素水平的治疗剂

CASR调节剂的药物组合物及其方法和用途

Pharmaceutical compositions of CASR modulators and methods and uses thereof

用于降低甲状旁腺激素水平的治疗剂

Calcimimetics and methods for their use

Therapeutic Agents For Reducing Parathyroid Hormone Levels

USE OF 2-METHYLENE-19-NOR-(20S)-1,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM 2--19--(20S)-125- D3

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database